Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

By Chen Weizao   Ying Tianlei   Dimitrov Dimiter S  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-06 ,pp. : 657-671

Informa Healthcare

Access to resources Recommend Favorite

Binding of High-Mannose-Type Oligosaccharides and Synthetic Oligomannose Clusters to Human Antibody 2G12 - Implications for HIV-1 Vaccine Design

By Wang L.-X.   Ni J.   Singh S.   Li H.  

Chemistry & Biology, Vol. 11, Iss. 1, 2004-01 ,pp. : 127-134

Elsevier

Access to resources Recommend Favorite

Gene therapy as a vaccine for HIV-1

By Berkhout Ben   Sanders Rogier W  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 10, 2012-10 ,pp. : 1315-1321

Informa Healthcare

Access to resources Recommend Favorite

The Binding Energetics of First- and Second-Generation HIV-1 Protease Inhibitors: Implications for Drug Design

By Velazquez-Campoy A.   Kiso Y.   Freire E.  

Archives of Biochemistry and Biophysics, Vol. 390, Iss. 2, 2001-06 ,pp. : 169-175

Elsevier

Access to resources Recommend Favorite

Improved outlook on HIV-1 prevention and vaccine development

By Vasan Sandhya   Michael Nelson L  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 983-994

Informa Healthcare

Access to resources Recommend Favorite